Skip to content
AnalystLens

DuPont de Nemours 8-K Report, Financial Results (Aug 4, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed August 4, 2026
Period End
August 4, 2026
Security
DD
In the record · 2017–202610-K910-Q288-K127

DD filed 9 annual reports (10-K), 28 quarterly reports (10-Q) and 127 current reports (8-K) between 2017 and 2026.

  1. Leadership change8-K · Jun ’18Jun ’18
  2. Leadership change8-K · May ’20May ’20
  3. Material agreement8-K · Feb ’22Feb ’22
  4. Material agreement8-K · Nov ’25Nov ’25

01—Abstract

Summary

Summary of the 8-K filed August 4, 2026. Cited figures are marked; the original filing is the authoritative source.

DuPont de Nemours, Inc. reported second quarter 2026 results in an Item 2.02 8-K, furnishing a press release as Exhibit 99.1.

Net sales rose 4% to $1,819 milliona, with organic sales also up 4%. GAAP income from continuing operations was $191 million, compared with $24 million a year earlier, and GAAP EPS from continuing operations was $1.37. Operating EBITDA increased 6% to $448 million, with an operating EBITDA margin of 24.6% versus 24.2%.

Adjusted EPS was $1.88b versus $1.27, up 48%. Cash provided by operating activities from continuing operations was $400 million, and capital expenditures were $76 million. Transaction-adjusted free cash flow was $326 million, up from $107 million, representing 127% conversion.

The company also announced its intent to repurchase $250 millionc of shares in the third quarter, and stated that its GICS classification changed to Industrials effective July 31, 2026. DuPont raised its full-year 2026 guidance. Full-year net sales are now expected at $7,160 million to $7,190 million, operating EBITDA at $1,750 million to $1,770 million, and adjusted EPS at $7.17 to $7.32.

The CFO stated the operating EBITDA midpoint is approximately $1.76 billiond, the adjusted EPS midpoint is $7.24, and organic sales growth is expected to be slightly above 4%, with mid-single digit organic growth expected in the second half. Results are presented on a continuing operations basis following the Aramids divestiture (completed April 1, 2026) and the Electronics separation into Qnity (November 1, 2025), and a 1-for-3 reverse stock split became effective June 24, 2026.

02—Key points

Key Highlights

  1. Q2 2026 net sales of $1,819 million, up 4% (organic growth of 4%); Healthcare & Water Technologies up 5% and Diversified Industrials up 3%
  2. GAAP income from continuing operations of $191 million versus $24 million in Q2 2025; GAAP EPS from continuing operations of $1.37
  3. Operating EBITDA of $448 million, up 6%, with margin of 24.6% versus 24.2%; adjusted EPS of $1.88 versus $1.27, up 48%
  4. Transaction-adjusted free cash flow of $326 million versus $107 million, representing 127% conversion
  5. Raised full-year 2026 guidance: operating EBITDA of $1,750–$1,770 million and adjusted EPS of $7.17–$7.32, with the midpoint of adjusted EPS at $7.24
  6. Announced intent to repurchase $250 million of shares in the third quarter of 2026
  7. Aramids divestiture completed April 1, 2026, for approximately $1.2 billion in pre-tax cash proceeds, a $300 million note receivable, and a non-controlling equity interest valued at $325 million

03—Questions

Frequently Asked Questions

  1. How did DuPont perform in the second quarter of 2026?

    Net sales rose 4% to $1,819 million on 4% organic growth. Operating EBITDA increased 6% to $448 million, and adjusted EPS grew to $1.88 from $1.27. GAAP income from continuing operations was $191 million, up from $24 million.

  2. Did DuPont change its 2026 outlook?

    Yes. The company raised full-year 2026 guidance, now projecting net sales of $7,160–$7,190 million, operating EBITDA of $1,750–$1,770 million, and adjusted EPS of $7.17–$7.32. The CFO said organic sales growth is now expected to be slightly above 4%, with mid-single digit organic growth in the second half.

  3. How strong was cash generation?

    Cash provided by operating activities from continuing operations was $400 million, with capital expenditures of $76 million. Transaction-adjusted free cash flow was $326 million, compared with $107 million a year earlier, representing 127% conversion.

  4. What capital return actions did DuPont announce?

    DuPont announced its intent to repurchase $250 million of shares in the third quarter of 2026. The filing also notes that a 1-for-3 reverse stock split became effective June 24, 2026.

  5. What portfolio changes affect the reported results?

    The Aramids business was sold to Arclin on April 1, 2026, and its results are reported as discontinued operations. The Electronics business was separated into Qnity Electronics on November 1, 2025, and is also presented as discontinued operations. Results are shown on a continuing operations basis.

04—Continue

← View all 8-K filings